Bausch & Lomb (BLCO) reported $5.1B in revenue for fiscal 2025, +6.5% year on year. That ranks #802 by revenue among 2853 SEC filers and #71 in Healthcare. It posted a net loss of −$360M for the same year. Revenue has grown 8.4% a year on average since 2020 ($3.4B then). The fiscal 2025 balance sheet shows $14.0B in total assets, $383M in cash and $5.0B in long-term debt.
Key figures
| Key figures | FY2025 | YoY | Source |
|---|---|---|---|
| RevenueRevenueFromContractWithCustomerExcludingAssessedTax | $5.1B | +6.5% | FY20252025-12-31 |
| Gross profit | Not reported | — | |
| Operating incomeOperatingIncomeLoss | $113M | −30.2% | FY20252025-12-31 |
| Net incomeNetIncomeLoss | −$360M | −$43.0M | FY20252025-12-31 |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | $283M | +22.0% | FY20252025-12-31 |
| Capital expenditurePaymentsToAcquirePropertyPlantAndEquipment | $349M | +19.9% | FY20252025-12-31 |
| Total assetsAssets | $14.0B | +4.1% | FY20252025-12-31 |
| Shareholders' equityStockholdersEquity | $6.4B | −0.4% | FY20252025-12-31 |
| CashCashAndCashEquivalentsAtCarryingValue | $383M | +25.6% | FY20252025-12-31 |
| Long-term debtLongTermDebtNoncurrent | $5.0B | +5.8% | FY20252025-12-31 |
Revenue is total net sales for the fiscal year, taken from each company's own annual filing.
Reported since the last full year
Three-month figures this company has filed since FY2025. A quarter is not comparable with a full year, and these figures are used nowhere else on the site: not in any ranking, not in comparisons, not in the download.
| Quarter | Revenue | Net income | Source |
|---|---|---|---|
| Q1 20262026-03-31 | $1.2B | −$71.0M | Open → |
| Q2 20262026-06-30 | $1.4B | −$14.0M | Open → |
Only periods that end on a calendar quarter appear here. A company whose fiscal year ends in June files on a different calendar, so it has no row.
Where this sits in its sector
Each bar is the spread of the whole sector: the box covers the middle half of companies, the line inside it the median, and the triangle this company. The axis is clipped at the 5th and 95th percentile so a single outlier does not flatten it.
| Where this sits in its sector | FY2025 | Position in sector |
|---|---|---|
| Net marginRank 136 of 161 companies compared | −7.1% | |
| Operating marginRank 118 of 160 companies compared | 2.2% | |
| R&D as share of revenueRank 55 of 102 companies compared | 7.3% | |
| Cash as share of revenueRank 106 of 160 companies compared | 7.5% |
All four are ratios derived from two reported lines, not single filing items. Peer group: companies in the same sector with revenue of $1bn or more; loss-making companies are included.
Profile
- Legal name
- Bausch & Lomb Corp
- Ticker
- BLCO
- Exchange
- NYSE
- SIC classification
- Ophthalmic Goods (3851)
- Fiscal year end
- 12-31
- CIK
- 0001860742
Filings
- 10-QJul 29, 2026Open filing →
- 10-QApr 29, 2026Open filing →
- 10-KFeb 18, 2026Open filing →
Similar in size, same sector
| Company | Revenue | Net income |
|---|---|---|
| Pacs GroupPACS | $5.3B | $192M |
| ResmedRMD | $5.1B | $1.4B |
| IncyteINCY | $5.1B | $1.3B |
| Bausch & LombBLCO | $5.1B | −$360M |
| Ensign GroupENSG | $5.1B | $344M |
| HerbalifeHLF | $5.0B | $228M |
| Elanco Animal HealthELAN | $4.7B | −$232M |
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Bausch & Lomb — Key figures |url=https://companiesranked.com/en/company/bausch-and-lomb |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Bausch & Lomb — Key figures. CompaniesRanked. https://companiesranked.com/en/company/bausch-and-lombBibTeX
@misc{companiesranked-en-company-bausch-and-lomb-2026,
author = {{CompaniesRanked}},
title = {{Bausch \& Lomb — Key figures}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/bausch-and-lomb}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-K · 0001860742-26-000007 · February 18, 2026
{{cite web |title=Bausch & Lomb — Key figures — 10-K (0001860742-26-000007) |url=https://www.sec.gov/Archives/edgar/data/1860742/000186074226000007/blco-20251231.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-02-18}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.